| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000013360 |
| Receipt No. | R000015554 |
| Scientific Title | Evaluation of the usefulness of Contrast-enhanced US using Sonazoid for Postpartum hemorrhage (PPH) |
| Date of disclosure of the study information | 2014/06/01 |
| Last modified on | 2020/03/10 (Ver. 3) |
| Basic information | ||
| Public title | Evaluation of the usefulness of Contrast-enhanced US using Sonazoid for Postpartum hemorrhage (PPH) | |
| Acronym | Diagnosis of PPH using Sonazoid | |
| Scientific Title | Evaluation of the usefulness of Contrast-enhanced US using Sonazoid for Postpartum hemorrhage (PPH) | |
| Scientific Title:Acronym | Diagnosis of PPH using Sonazoid | |
| Region |
|
|
| Condition | ||
| Condition | Postpartum hemorrhage | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | For the quick diagnosis and treatment, we will evaluate the usefulness of Contrast-enhanced US using Sonazoid for Postpartum hemorrhage (PPH). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We will use Contrast-enhanced US using Sonazoid for Postpartum hemorrhage (PPH), and time to start of treatment followed by the exact diagnosis will be evaluated. The data will be reviewed with the technique of Inflow-Time Mapping later on. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Sonazoid | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Postpartum hemorrhage without any other complication | |||
| Key exclusion criteria | In the case with no benefit of the present technique for PPH | |||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Juntendo University | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 113-8421 | ||||||
| Address | 2-1-1 Hongo Bunkyoku Tokyo, 113-8421, Japan | ||||||
| TEL | 03-3813-3111 | ||||||
| shintaro@juntendo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Juntendo University | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 113-8421 | ||||||
| Address | 2-1-1 Hongo Bunkyoku Tokyo, 113-8421, Japan | ||||||
| TEL | 03-3813-3111 | ||||||
| Homepage URL | |||||||
| shintaro@juntendo.ac.jp | |||||||
| Sponsor | |
| Institute | Juntendo University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Juntendo University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Juntendo Clinical Research and Trial Center |
| Address | 2-1-1 Hongo Bunkyoku Tokyo, 113-8421, Japan |
| Tel | 03-3813-3111 |
| chiken@juntendo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015554 |